Case ID	Project	Primary Site	Gender	Files	Seq	Exp	SNV	CNV	Meth	Clinical	Bio	# Mutations	# Genes	Slides
TCGA-A5-A1OF	TCGA-UCEC	Corpus uteri	Female	68	6	4	16	11	3	11	16	1	1	2
C3N-01871	CPTAC-3	Uterus, NOS	Female	39	8	4	16	2	3	0	0	1	1	0
TCGA-CA-6718	TCGA-COAD	Colon	Male	75	10	4	16	11	3	9	17	1	1	3
C3N-01071	CPTAC-3	Bronchus and lung	Male	62	15	8	21	2	6	0	0	1	1	0
TCGA-A1-A0SP	TCGA-BRCA	Breast	Female	73	8	4	16	11	3	12	15	1	1	3
C3N-00151	CPTAC-3	Uterus, NOS	Female	48	11	6	16	2	3	0	0	1	1	0
TCGA-G4-6299	TCGA-COAD	Colon	Male	73	8	4	16	11	3	9	17	1	1	3
TCGA-D3-A2JE	TCGA-SKCM	Skin	Female	68	6	4	16	11	3	9	14	1	1	2
TCGA-BR-6709	TCGA-STAD	Stomach	Female	80	11	4	17	14	3	8	18	1	1	4
TCGA-CV-5441	TCGA-HNSC	Larynx	Male	77	8	4	16	11	6	10	17	1	1	3
TCGA-LL-A9Q3	TCGA-BRCA	Breast	Female	72	8	4	16	11	3	11	14	1	1	2
TCGA-CG-4437	TCGA-STAD	Stomach	Male	72	8	4	16	11	3	8	17	1	1	3
TCGA-A5-A0G2	TCGA-UCEC	Corpus uteri	Female	69	8	4	16	9	3	11	17	2	1	3
TCGA-EO-A3AU	TCGA-UCEC	Corpus uteri	Female	72	6	4	16	11	3	11	16	1	1	2
TCGA-CR-7379	TCGA-HNSC	Other and ill-defined sites in lip, oral cavity and pharynx	Female	71	8	4	16	11	3	10	15	1	1	1
TARGET-10-PARCFM	TARGET-ALL-P2	Hematopoietic and reticuloendothelial systems	Male	20	2	0	14	0	0	3	1	1	1	0
TCGA-D8-A141	TCGA-BRCA	Breast	Female	73	8	4	16	11	3	11	16	1	1	4
C3L-02449	CPTAC-3	Uterus, NOS	Female	43	12	6	14	0	3	0	0	1	1	0
TCGA-J2-A4AG	TCGA-LUAD	Bronchus and lung	Female	75	8	4	16	11	3	8	20	1	1	2
TCGA-G2-A2EF	TCGA-BLCA	Bladder	Male	77	12	4	16	11	3	10	17	1	1	5
TCGA-5A-A8ZF	TCGA-CHOL	Liver and intrahepatic bile ducts	--	39	4	0	14	0	0	8	13	1	1	1
TCGA-FS-A1ZE	TCGA-SKCM	Skin	Male	68	8	4	16	11	3	8	14	1	1	2